Maze Therapeutics has completed a Series D financing round, raising $115m to propel the development of its lead candidates, ...

President-elect Donald Trump and his incoming administration are unlikely to attempt a wholesale restructuring of U.S.

In older patients discharged after hospitalization for heart failure, many spend the majority of the first year alive and at home.

IGM Biosciences has pivoted from cancer therapeutics to autoimmune diseases despite setbacks, showing a 25% stock increase since last October. Click for more on IGMS.

COVID-19 vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in Czech Republic to Wegovy-maker ...

With the purchase of a plant in the Czech Republic, Novo Nordisk is saying “jak se máš” to hundreds of new employees—and ...

Not exactly known for its dealmaking, Sarepta Therapeutics has thrown down a massive wad of cash to work with Arrowhead ...

Navitas Semiconductor is losing money according to Jim Cramer. LandBridge Company is a winner, while Regeneron is facing ...

As the MHRA begins a new chapter, the ABPI has published a report outlining the importance of regulatory excellence in the UK ...

Comparison measures of lung function and improved categorization of cardiovascular disease (CVD) risk were among the key ...

Sanofi (SNY) intends to spend about $1.05B building a new insulin manufacturing base in China, Kimberley Kao of The Wall Street Journal ...

In a bid to bolster pandemic preparedness, Sanofi has opened a modular vaccine manufacturing plant in Tuas Biomedical Park, Singapore.